Several lymphocyte subsets were enriched in NC-GBM tumors, including γδ T cells and CD8–CD4– DNT cells, as well as CD8+ T cells, NK cells, and B cells, which correlated with improved patient survival. The gene discussed is CD8A; the disease is glioblastoma.